The PTEN gene encodes a negative regulator of the PI3K/Akt/mTOR pathway and is one of the most frequently mutated genes in cancer, with loss of heterozygosity at the PTEN locus being reported in about 40% of invasive BC [6,7]. This evidence concerns the gene PTEN and breast cancer.